🔓
Sign in as a Member to unlock the full view of INCY. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
INCY

Incyte Corporation

Sector: healthcareBiotechnologyNASDAQMarket Cap: $20.16B

Incyte Corporation is a biopharmaceutical company focused on oncology and inflammation, with its most significant political signal being $13.1M in annual payments to doctors and a direct equity holding by a former President.

Next filing → your inbox
Govt Dependence
2/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat INCY does

Incyte Corporation is a biopharmaceutical company that discovers, develops, and commercializes proprietary therapeutics, primarily in oncology and inflammation/autoimmunity. Its key revenue driver is the JAK inhibitor Jakafi (ruxolitinib) for myelofibrosis and polycythemia vera. The company also commercializes other oncology products and has a pipeline of clinical-stage candidates.

12 months past · 3 months futureINCY activity timeline

$134$111$88 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $129.93 hi $90.30 lo $120.97 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 30 Ro Khanna (D) · Sale · 2026-10-07Ro Khanna (D) · Purchase · 2026-09-04Ro Khanna (D) · Purchase · 2026-01-29 AQR Capital Management · - $603M · 2026-06-30AQR Capital Management · OPENED $536M · 2026-03-31Renaissance Technologies · - $404M · 2026-09-30Renaissance Technologies · holds $398M · 2026-06-30Renaissance Technologies · - $393M · 2025-12-31Renaissance Technologies · - $344M · 2026-03-31Two Sigma Investments · + $227M · 2026-06-30Two Sigma Investments · + $39M · 2026-03-31Citadel Advisors · + $34M · 2026-06-30Bridgewater Associates · + $32M · 2025-12-31Bridgewater Associates · + $19M · 2026-06-30 HR.2001 · passed_one · 2026-07-21 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
249 trading days · 3 congressional trades shown · 0 insider buys · 11 13F filings · 1 past bill actions · 5 upcoming markups

Executive Branch ConflictsINCY held by Trump-administration officials

Lifetime Government AwardsINCY federal contracts by year

$686K
total awarded · 2012–2024
51
contracts on file
2012
peak year ($204K)
$204K $102K 2012: $204K across 27 contracts (peak year) $204K 2012 27 contracts 2017: $17K across 1 contract $17K 2017 2020: $76K across 6 contracts $76K 2020 6 contracts 2021: $89K across 3 contracts $89K 2021 3 contracts 2022: $25K across 1 contract $25K 2022 2023: $115K across 9 contracts $115K 2023 9 contracts 2024: $159K across 4 contracts $159K 2024 4 contracts
Top contracts by award amount
$120K Department of Veterans Affairs 2024-07-02 PEMIGATINIB
$64K Department of Veterans Affairs 2021-01-19 PEMAZYRE 13.5
$31K Department of Veterans Affairs 2012-03-19 JAKAFI
$25K Department of Veterans Affairs 2022-04-27 PEMAZYRE
$17K Department of Health and Human Serv 2017-02-16 IGF::OT::IGF MEDICAL TECHNOLOGIST STAFFING SVC - YSU
13 years · 51 contracts

Smart Money · 13F HoldingsHedge funds holding INCY

$1.29B
Total INCY held by tracked 13F funds
6
Funds with INCY positions
AQR Capital Management $603M -8% 2026-06-30
Renaissance Technologies $404M -5% 2 overlap 2026-09-30
Two Sigma Investments $227M +382% 2026-06-30
Citadel Advisors $34M +120% 2026-06-30
Bridgewater Associates $19M +29% 2026-06-30
D.E. Shaw & Co. $818K +126% 2026-06-30

Politicians Trading INCYMembers of Congress with recent INCY positions

2 politicians traded INCY across 11 disclosed transactions totaling $88K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just INCY). 0-30 LOW · 30-60 MID · 60+ HIGH.

Congressional TradesWho in Congress is trading INCY

2026-10-07 Ro Khanna D-California · house Sale $1,001 - $15,000
2026-09-04 Ro Khanna D-California · house Purchase $1,001 - $15,000
2026-01-29 Ro Khanna D-California · house Purchase $1,001 - $15,000
2025-05-19 Ro Khanna D-California · house purchase $1,001 - $15,000
2025-05-19 Ro Khanna D-California · house Purchase $1,001 - $15,000
2025-05-15 Robert P. Bresnahan R-Pennsylvania · house sale $1,001 - $15,000
2025-05-15 Robert P. Bresnahan R-Pennsylvania · house Sale $1,001 - $15,000
2025-02-19 Ro Khanna D-California · house sale $1,001 - $15,000
2025-02-19 Ro Khanna D-California · house Sale $1,001 - $15,000
2025-01-17 Ro Khanna D-California · house purchase $1,001 - $15,000
2025-01-17 Ro Khanna D-California · house Purchase $1,001 - $15,000
2024-11-15 Ro Khanna D-California · house purchase $1,001 - $15,000
30+ trades on file · most recent 2026-11-05

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

17
stock awards · $10.4M market value
41
option exercises · $25.1M
2026-09-30 BAKER BROS. ADVISORS LP Director AWARD 322 sh $39K
2026-09-30 BAKER BROS. ADVISORS LP Director AWARD 322 sh $39K
2026-09-30 HARRIGAN EDMUND Director AWARD 206 sh $25K
2026-09-30 Clancy Paul J Director AWARD 203 sh $25K
2026-07-16 Meury William Chief Executive Officer AWARD 26,807 sh $3.1M
2026-07-16 CAGNONI PABLO J President, Global Head of R&D AWARD 13,403 sh $1.6M
2026-07-16 Stein Steven H CMO & Head of Late-Stage Dev. AWARD 9,798 sh $1.1M
2026-07-16 Issa Mohamed Khairie EVP, Head of U.S. Commercial AWARD 7,857 sh $917K
For INCY, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting INCYLive legislation impacting this stock

Political ProfileWhere INCY sits in Washington

[object Object]

STRUCTURAL: High regulatory density (85) from 8 pending healthcare bills and a major physician payment program ($13.1M in 2024). EVIDENTIARY: Direct equity holding by a former President (`get_executive_branch_exposure.by_ticker[0].holdings`) and repeated congressional purchases by Rep. Khanna. Net: Evidentiary bullish signals are offset by a lack of formal lobbying infrastructure and a congressional critic, resulting in a neutral net signal.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Heightened scrutiny of physician payment programs under the Sunshine Act
    CMS
    "`get_political_influence.doctor_payments` shows 77,681 payments totaling $13.1M in 2024, a high-volume program vulnerable to regulatory review."

Regulatory opportunities

  • Veterans Affairs formulary inclusion for oncology products
    Department of Veterans Affairs
    "`get_government_precedent.federal_contracts_summary[0]` shows 18 contracts with the VA totaling $401.5K, establishing a procurement precedent."

Capitol Hill AlliesChampions & critics

Congressional champions

Congressional critics

Member intelligence layer

Live signals + predictions for INCY — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout INCY & political exposure

Does Incyte Corporation (INCY) hold federal contracts?
Yes. Incyte Corporation has 51 federal contract awards totaling $685,672, primarily from agencies including Department of Health and Human Services, Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own INCY stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in INCY on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded INCY stock?
99 congressional trades by 6 unique members of Congress, most recently on 2026-10-07. See the Congressional Trading panel for politician-by-politician breakdown.
What is INCY political risk profile?
Government dependence: 2/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track INCY political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. INCY data is updated daily from these official federal sources.